TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8917929

Group type: EXPERIMENTAL
Intervention: Difficult suggestions
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Easy suggestions
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Posthypnotic suggestion
Number of subjects: 78
Study: 2643423

Group type: EXPERIMENTAL
Intervention: 38% fat treatment diet (9% saturated fat, 15% polyunsaturated fat, 14% monounsaturated fat, 166 mg dietary cholesterol per day)
Number of subjects: 9057

Group type: COMPARATOR
Intervention: 39% fat control diet (18% saturated fat, 5% polyunsaturated fat, 16% monounsaturated fat, 446 mg dietary cholesterol per day)
Number of subjects: 9057

Group type: EXPERIMENTAL
Intervention: Both treatment and control diets
Number of subjects: 9057
Study: 1095962

Group type: EXPERIMENTAL
Intervention: 15 mg SAMe i.v. or i.m. administered four times a day for 30 days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Equimolecular doses of L-methionine and ATP
Number of subjects: 15
Study: 30455321

Group type: EXPERIMENTAL
Intervention: Obinutuzumab plus background therapy of mycophenolate and steroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus background therapy of mycophenolate and steroids
Number of subjects: 0
Study: 28499272

Group type: EXPERIMENTAL
Intervention: 10 mg hydrocortisone
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 25749542

Group type: EXPERIMENTAL
Intervention: Combination therapy plus famciclovir (antiviral treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination therapy (control group)
Number of subjects: 0
Study: 23429062

Group type: COMPARATOR
Intervention: Higher body mass index and less likely to report estrogen or aspirin use
Number of subjects: 37459

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 37459

Group type: EXPERIMENTAL
Intervention: Previous hysterectomy
Number of subjects: 37459

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 37459
Study: 21447772

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 19547811

Group type: EXPERIMENTAL
Intervention: bromazepam 3 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: bromazepam 6 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 45
Study: 16297442

Group type: EXPERIMENTAL
Intervention: Prescription-based counseling and self-monitoring (MON)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Self-monitoring (MON)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 265
Study: 15611808

Group type: EXPERIMENTAL
Intervention: tiotropium and fluticasone/salmeterol
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: tiotropium and salmeterol
Number of subjects: 432

Group type: COMPARATOR
Intervention: tiotropium and placebo inhaler
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: not specified
Number of subjects: 432
Study: 11414874

Group type: EXPERIMENTAL
Intervention: naltrexone hydrochloride (1.5 mg/kg/day)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 9241008

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/day on days 8-17 followed by 30 mg/day on days 18-20)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sertraline (50 mg/day on days 8-17 and 100 mg/day on days 18-20)
Number of subjects: 24
Study: 8098758

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neostigmine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Idazoxan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ST-91
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonidine (epidural administration in human volunteers)
Number of subjects: 0
Study: 3122189

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 71

Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 71
Study: 31228563

Group type: EXPERIMENTAL
Intervention: Models adjusted for important baseline confounders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher outcome intraclass correlation coefficients
Number of subjects: 0
Study: 29778971

Group type: EXPERIMENTAL
Intervention: Supraclavicular block with ropivacaine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Infraclavicular block with ropivacaine
Number of subjects: 150
Study: 27692498

Group type: EXPERIMENTAL
Intervention: ixekizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: etanercept
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 24752165

Group type: EXPERIMENTAL
Intervention: Sugammadex (SUG group)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Neostigmine (NEO group)
Number of subjects: 88
Study: 22333855

Group type: EXPERIMENTAL
Intervention: Multimedia learning tool (MMLT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Textbook excerpt
Number of subjects: 25
Study: 21044535

Group type: EXPERIMENTAL
Intervention: Project-based intervention using the PREDEA curriculum, 30 minutes daily from mid December to mid June.
Number of subjects: 1123

Group type: COMPARATOR
Intervention: Control group receiving available remedial services at their schools.
Number of subjects: 1123
Study: 18415758

Group type: EXPERIMENTAL
Intervention: 3-l sulphate-free polyethylene glycol solution (SF-PEG)
Number of subjects: 110

Group type: COMPARATOR
Intervention: 4-l polyethylene glycol solution (PEG)
Number of subjects: 110
Study: 16206502

Group type: EXPERIMENTAL
Intervention: Gluten pretreated with prolyl endopeptidase (PEP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gluten not treated with PEP
Number of subjects: 20
Study: 11839625

Group type: EXPERIMENTAL
Intervention: Norepinephrine analogue [123I]m‐iodobenzylguanidine (123I‐MIBG) SPECT
Number of subjects: 17
Study: 10369627

Group type: EXPERIMENTAL
Intervention: Macrolide therapy (azithromycin or roxithromycin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlamydia pneumoniae infection
Number of subjects: 0
Study: 7772935

Group type: EXPERIMENTAL
Intervention: 75-g oral glucose tolerance test
Number of subjects: 32

Group type: COMPARATOR
Intervention: 100-g oral glucose tolerance test
Number of subjects: 32
Study: 2181138

Group type: EXPERIMENTAL
Intervention: Acupressure using elasticated bands with a plastic button at the P6 point
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control dummy bands without the pressure button
Number of subjects: 162

Group type: COMPARATOR
Intervention: Antiemetic injections of prochlorperazine
Number of subjects: 162
Study: 834983

Group type: EXPERIMENTAL
Intervention: Spironolactone (400 mg/day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Mefruside (mean maximal dose 110 mg/day)
Number of subjects: 35
Study: 31221693

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) - 10 sessions over 12 weeks
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Community-based exercise (EXER) - 12 weeks including six sessions with a personal trainer
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy + Community-based exercise (CBT+EXER) - concurrent over a 12-week period
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 140
Study: 28082261

Group type: EXPERIMENTAL
Intervention: Hydrogel coils
Number of subjects: 447

Group type: COMPARATOR
Intervention: Bare platinum coils
Number of subjects: 447
Study: 24622577

Group type: COMPARATOR
Intervention: Cold-water immersion (CWI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study: 22784417

Group type: EXPERIMENTAL
Intervention: Ridge preservation with corticocancellous porcine bone and a collagen membrane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with silk sutures and no grafting material
Number of subjects: 0
Study: 21701378

Group type: EXPERIMENTAL
Intervention: Fixed-jaw group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Free-jaw group
Number of subjects: 20
Study: 18716392

Group type: EXPERIMENTAL
Intervention: Internet-based self-help program (2 weeks duration)
Number of subjects: 43
Study: 17063135

Group type: EXPERIMENTAL
Intervention: 3-component model (3CM) intervention
Number of subjects: 224
Study: 14513925

Group type: EXPERIMENTAL
Intervention: Zolpidem (10 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (1 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 11210856

Group type: EXPERIMENTAL
Intervention: P&B 2.1
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: P&B 2.1/NaOCl
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SB
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SB/NaOCl
Number of subjects: 80
Study: 9170478

Group type: EXPERIMENTAL
Intervention: Home monitoring with a meter
Number of subjects: 342

Group type: COMPARATOR
Intervention: Clinic follow-up
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Breakfast test cutoff of 7.8 mmol/L
Number of subjects: 342
Study: 1554179

Group type: COMPARATOR
Intervention: 5 mg haloperidol IM
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 5 mg droperidol IM
Number of subjects: 68

Group type: COMPARATOR
Intervention: haloperidol IV
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 5 mg droperidol IV
Number of subjects: 68
Study: 4033866

Group type: EXPERIMENTAL
Intervention: Ethanol (1.4 ml 100 proof vodka/kg body weight)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (0 ml vodka)
Number of subjects: 31
Study: 30936687

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 164

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 164
Study: 30456520

Group type: EXPERIMENTAL
Intervention: Iron Isomaltoside (IIM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ferric Carboxymaltose (FCM)
Number of subjects: 0
Study: 27110446

Group type: EXPERIMENTAL
Intervention: Family-based prevention program (intervention)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 191
Study: 22515728

Group type: EXPERIMENTAL
Intervention: 1% zinc pyrithione (ZPT) shampoo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo cosmetic shampoo
Number of subjects: 0
Study: 22709609

Group type: EXPERIMENTAL
Intervention: Web-based brief alcohol intervention (WDYD)
Number of subjects: 750

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 750
Study: 20579404

Group type: EXPERIMENTAL
Intervention: High-total antioxidant capacity (HT) diet
Number of subjects: 19

Group type: COMPARATOR
Intervention: Low-total antioxidant capacity (LT) diet
Number of subjects: 19
Study: 16520435

Group type: EXPERIMENTAL
Intervention: d-cycloserine (50 mg)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 14652120

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 26

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 26
Study: 10646124

Group type: EXPERIMENTAL
Intervention: Pamidronate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ibandronate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clodronate
Number of subjects: 60
Study: 9296406

Group type: EXPERIMENTAL
Intervention: Ondansetron (0.1 mg/kg to 4 mg intravenously)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study: 8445378

Group type: EXPERIMENTAL
Intervention: Behavioral group therapy (N = 30)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Individual behavior therapy (N = 31)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Progressive muscle relaxation (Control group, N = 32)
Number of subjects: 93
Study: 3296296

Group type: EXPERIMENTAL
Intervention: Twice daily beclomethasone dipropionate (500 micrograms/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Four times daily standard dose inhaler (400 micrograms/day)
Number of subjects: 21
Study: 30815880

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Entecavir (ETV)
Number of subjects: 27
Study: 28930879

Group type: EXPERIMENTAL
Intervention: Dehydration protocol (DHY: 3‐hour cycling at 60 W in 40° C to induce 5% dehydration)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Dehydration protocol (DHY)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Thermoneutral control (CONT)
Number of subjects: 14
Study: 26681403

Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg/kg, intraperitoneally) in rats
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg/day, orally) in humans
Number of subjects: 95

Group type: COMPARATOR
Intervention: Oral placebo (control group) in humans
Number of subjects: 95
Study: 24983706

Group type: EXPERIMENTAL
Intervention: Combined AIT and strength training (COM)
Number of subjects: 42

Group type: COMPARATOR
Intervention: High-intensity aerobic interval training (AIT)
Number of subjects: 42
Study: 22968523

Group type: EXPERIMENTAL
Intervention: ferumoxytol 1 g
Number of subjects: 15
Study: 20935398

Group type: EXPERIMENTAL
Intervention: AScVS (anti-scorpion venom serum) administered as an intravenous slow bolus, ranging from 40 to 100 ml depending on severity
Number of subjects: 81

Group type: COMPARATOR
Intervention: Prazosin given as 1 mg every 3 h
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: AScVS + prazosin
Number of subjects: 81
Study: 18802155

Group type: EXPERIMENTAL
Intervention: Alendronate 70 mg once weekly
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Alendronate initiated in year 2
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Alendronate for 2 years
Number of subjects: 112
Study: 17257724

Group type: EXPERIMENTAL
Intervention: IMB intervention (Information‐Motivation‐Behavioral Skills model)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Information‐only control condition
Number of subjects: 250
Study: 14499232

Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise training for 8 weeks in treated subjects
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise training for 8 weeks in untreated subjects
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (treated subjects)
Number of subjects: 22
Study: 10707914

Group type: EXPERIMENTAL
Intervention: Vigorous physical exertion
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Sedentary subjects
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Socioeconomic status
Number of subjects: 699

Group type: COMPARATOR
Intervention: Healthy subjects (case-crossover analysis)
Number of subjects: 699
Study: 9088805

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Lithium and Carbamazepine
Number of subjects: 90
Study: 8450893

Group type: EXPERIMENTAL
Intervention: Amitriptyline oxide (AO) 60-90 mg
Number of subjects: 197

Group type: COMPARATOR
Intervention: Amitriptyline (AM) 50-75 mg
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 197
Study: 2876658

Group type: EXPERIMENTAL
Intervention: 5 mg slow-release terbutaline sulphate tablets (Bricanyl Depot) given twice daily
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ordinary oral beta 2-agonist treatment given three times daily
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 5 mg slow-release terbutaline sulphate tablets (Bricanyl Depot)
Number of subjects: 18
Study: 31464643

Group type: EXPERIMENTAL
Intervention: Bikram yoga
Number of subjects: 34

Group type: COMPARATOR
Intervention: HIIT
Number of subjects: 34
Study: 28028288

Group type: EXPERIMENTAL
Intervention: Self-debriefing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Instructor debriefing
Number of subjects: 50
Study: 26271141

Group type: EXPERIMENTAL
Intervention: Golimumab (GLM) 50 mg every 4 weeks for 48 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pamidronate (PAM) 60 mg every 4 weeks for 48 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Golimumab (GLM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pamidronate (PAM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Golimumab (GLM) and Pamidronate (PAM)
Number of subjects: 30
Study: 23889690

Group type: EXPERIMENTAL
Intervention: Intervention arm (specific intervention details not provided)
Number of subjects: 631

Group type: COMPARATOR
Intervention: Control group (specific control details not provided)
Number of subjects: 631
Study: 22103234

Group type: EXPERIMENTAL
Intervention: In-group robot
Number of subjects: 0

Group type: COMPARATOR
Intervention: Out-group robot
Number of subjects: 0
Study: 19207416

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training with slow movement and tonic force generation (LST) - approximately 55-60% one repetition maximum (1RM) load, 3 s lifting and 3 s lowering with no relaxation phase, n = 12
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High-intensity resistance training at normal speed (HN) - approximately 85-90% 1RM, 1 s lifting and 1 s lowering with 1 s relaxation, n = 12
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sedentary control (CON), n = 12
Number of subjects: 36
Study: 17475459

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 15620161

Group type: EXPERIMENTAL
Intervention: Femoral nerve approach in the inguinal region using a nerve stimulator
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Paravenous approach
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Transsartorial approach
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Subcutaneous infiltration between the tibial tuberosity and the internal gastrocnemius muscle
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Femoral nerve approach
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Subcutaneous infiltration
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Paravenous approach and subcutaneous infiltration
Number of subjects: 80
Study: 11508654

Group type: EXPERIMENTAL
Intervention: Sumatriptan 20 mg intranasally
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 9716275

Group type: EXPERIMENTAL
Intervention: Light therapy for 2 weeks
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Tryptophan therapy for 4 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Light therapy
Number of subjects: 13

Group type: COMPARATOR
Intervention: Tryptophan therapy
Number of subjects: 13
Study: 7989969

Group type: EXPERIMENTAL
Intervention: [11C]SCH 39166
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: [11C]NNC 756
Number of subjects: 12
Study: 2731087

Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Flunarizine and Placebo
Number of subjects: 34
Study: 29858919

Group type: EXPERIMENTAL
Intervention: Intravenous nicorandil
Number of subjects: 49

Group type: COMPARATOR
Intervention: Intravenous adenosine
Number of subjects: 49
Study: 28355039

Group type: EXPERIMENTAL
Intervention: Elevated vacuum suspension (EVS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nonelevated vacuum suspension (control)
Number of subjects: 10
Study: 25297012

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 4 g per day
Number of subjects: 513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 513
Study: 22345379

Group type: EXPERIMENTAL
Intervention: Having an Asthma Action Plan (AAP)
Number of subjects: 808

Group type: COMPARATOR
Intervention: Not having an Asthma Action Plan (AAP)
Number of subjects: 808
Study: 20483881

Group type: EXPERIMENTAL
Intervention: Standard care plus home telemonitoring
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 40
Study: 17651489

Group type: EXPERIMENTAL
Intervention: Referral process from GPs to CMHTs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CMHTs' operational practices
Number of subjects: 0
Study: 15647576

Group type: EXPERIMENTAL
Intervention: Intraoperative hypothermia (target temperature, 33 degrees C, using surface cooling techniques)
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Normothermia (target temperature, 36.5 degrees C)
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Intraoperative hypothermia
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 1001
Study: 12475511

Group type: EXPERIMENTAL
Intervention: Norian SRS (injectable calcium phosphate bone cement)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Functional treatment (displaced position accepted, not rereduced)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Norian SRS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Functional treatment
Number of subjects: 20
Study: 10424315

Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg once daily
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once daily
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine 60 mg
Number of subjects: 29
Study: 7565974

Group type: EXPERIMENTAL
Intervention: Annual in-home comprehensive geriatric assessment by gerontologic nurse practitioners
Number of subjects: 414

Group type: COMPARATOR
Intervention: Regular medical care (Control)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Annual in-home comprehensive geriatric assessment
Number of subjects: 414
Study: 1979462

Group type: EXPERIMENTAL
Intervention: Neuroleptics
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Combined therapy of neuroleptics and antidepressants
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Insulin coma therapy
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Symptomatic remedies
Number of subjects: 245
Study: 7438754

Group type: EXPERIMENTAL
Intervention: Ng-T device
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cu-T 200 device
Number of subjects: 200
Study: 31206586

Group type: EXPERIMENTAL
Intervention: New intervention for stroke
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0